EMEA-002578-PIP01-19-M01 - paediatric investigation plan
mozafancogene autotemcel
PIPHuman
Key facts
- Active Substance
- mozafancogene autotemcel
- Therapeutic area
- Blood and lymphatic system disorders
- Decision number
- P/0002/2024
- PIP number
- EMEA-002578-PIP01-19-M01
- Pharmaceutical form(s)
- Dispersion for infusion
- Condition(s) / indication(s)
- Treatment of Fanconi anaemia subtype A
- Route(s) of administration
- Intravenous use
- Contact for public enquiries
Rocket Pharmaceuticals, Inc.
Email: mz@rocketpharma.com
Tel. +34 682675494- Decision type
- PM: decision on the application for modification of an agreed PIP
- Decision date